Reconstruction of pathway modification induced by nicotinamide using multi-omic network analyses in triple negative breast cancer

Abstract Triple negative breast cancer (TNBC) is characterized by an aggressive biological behavior in the absence of a specific target agent. Nicotinamide has recently been proven to be a novel therapeutic agent for skin tumors in an ONTRAC trial. We performed combinatory transcriptomic and in-dept...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ji Young Kim, Hyebin Lee, Jongmin Woo, Wang Yue, Kwangsoo Kim, Seongmin Choi, Ja-June Jang, Youngsoo Kim, In Ae Park, Dohyun Han, Han Suk Ryu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9c37b2e0b7134150881904106462bd3e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9c37b2e0b7134150881904106462bd3e
record_format dspace
spelling oai:doaj.org-article:9c37b2e0b7134150881904106462bd3e2021-12-02T11:53:10ZReconstruction of pathway modification induced by nicotinamide using multi-omic network analyses in triple negative breast cancer10.1038/s41598-017-03322-72045-2322https://doaj.org/article/9c37b2e0b7134150881904106462bd3e2017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-03322-7https://doaj.org/toc/2045-2322Abstract Triple negative breast cancer (TNBC) is characterized by an aggressive biological behavior in the absence of a specific target agent. Nicotinamide has recently been proven to be a novel therapeutic agent for skin tumors in an ONTRAC trial. We performed combinatory transcriptomic and in-depth proteomic analyses to characterize the network of molecular interactions in TNBC cells treated with nicotinamide. The multi-omic profiles revealed that nicotinamide drives significant functional alterations related to major cellular pathways, including the cell cycle, DNA replication, apoptosis and DNA damage repair. We further elaborated the global interaction networks of molecular events via nicotinamide-inducible expression changes at the mRNA and functional protein levels. This approach indicated that nicotinamide treatment rewires interaction networks toward dysfunction in DNA damage repair and away from a pro-growth state in TNBC. To our knowledge, the high-resolution network interactions identified in the present study provide the first evidence to comprehensively support the hypothesis of nicotinamide as a novel therapeutic agent in TNBC.Ji Young KimHyebin LeeJongmin WooWang YueKwangsoo KimSeongmin ChoiJa-June JangYoungsoo KimIn Ae ParkDohyun HanHan Suk RyuNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ji Young Kim
Hyebin Lee
Jongmin Woo
Wang Yue
Kwangsoo Kim
Seongmin Choi
Ja-June Jang
Youngsoo Kim
In Ae Park
Dohyun Han
Han Suk Ryu
Reconstruction of pathway modification induced by nicotinamide using multi-omic network analyses in triple negative breast cancer
description Abstract Triple negative breast cancer (TNBC) is characterized by an aggressive biological behavior in the absence of a specific target agent. Nicotinamide has recently been proven to be a novel therapeutic agent for skin tumors in an ONTRAC trial. We performed combinatory transcriptomic and in-depth proteomic analyses to characterize the network of molecular interactions in TNBC cells treated with nicotinamide. The multi-omic profiles revealed that nicotinamide drives significant functional alterations related to major cellular pathways, including the cell cycle, DNA replication, apoptosis and DNA damage repair. We further elaborated the global interaction networks of molecular events via nicotinamide-inducible expression changes at the mRNA and functional protein levels. This approach indicated that nicotinamide treatment rewires interaction networks toward dysfunction in DNA damage repair and away from a pro-growth state in TNBC. To our knowledge, the high-resolution network interactions identified in the present study provide the first evidence to comprehensively support the hypothesis of nicotinamide as a novel therapeutic agent in TNBC.
format article
author Ji Young Kim
Hyebin Lee
Jongmin Woo
Wang Yue
Kwangsoo Kim
Seongmin Choi
Ja-June Jang
Youngsoo Kim
In Ae Park
Dohyun Han
Han Suk Ryu
author_facet Ji Young Kim
Hyebin Lee
Jongmin Woo
Wang Yue
Kwangsoo Kim
Seongmin Choi
Ja-June Jang
Youngsoo Kim
In Ae Park
Dohyun Han
Han Suk Ryu
author_sort Ji Young Kim
title Reconstruction of pathway modification induced by nicotinamide using multi-omic network analyses in triple negative breast cancer
title_short Reconstruction of pathway modification induced by nicotinamide using multi-omic network analyses in triple negative breast cancer
title_full Reconstruction of pathway modification induced by nicotinamide using multi-omic network analyses in triple negative breast cancer
title_fullStr Reconstruction of pathway modification induced by nicotinamide using multi-omic network analyses in triple negative breast cancer
title_full_unstemmed Reconstruction of pathway modification induced by nicotinamide using multi-omic network analyses in triple negative breast cancer
title_sort reconstruction of pathway modification induced by nicotinamide using multi-omic network analyses in triple negative breast cancer
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/9c37b2e0b7134150881904106462bd3e
work_keys_str_mv AT jiyoungkim reconstructionofpathwaymodificationinducedbynicotinamideusingmultiomicnetworkanalysesintriplenegativebreastcancer
AT hyebinlee reconstructionofpathwaymodificationinducedbynicotinamideusingmultiomicnetworkanalysesintriplenegativebreastcancer
AT jongminwoo reconstructionofpathwaymodificationinducedbynicotinamideusingmultiomicnetworkanalysesintriplenegativebreastcancer
AT wangyue reconstructionofpathwaymodificationinducedbynicotinamideusingmultiomicnetworkanalysesintriplenegativebreastcancer
AT kwangsookim reconstructionofpathwaymodificationinducedbynicotinamideusingmultiomicnetworkanalysesintriplenegativebreastcancer
AT seongminchoi reconstructionofpathwaymodificationinducedbynicotinamideusingmultiomicnetworkanalysesintriplenegativebreastcancer
AT jajunejang reconstructionofpathwaymodificationinducedbynicotinamideusingmultiomicnetworkanalysesintriplenegativebreastcancer
AT youngsookim reconstructionofpathwaymodificationinducedbynicotinamideusingmultiomicnetworkanalysesintriplenegativebreastcancer
AT inaepark reconstructionofpathwaymodificationinducedbynicotinamideusingmultiomicnetworkanalysesintriplenegativebreastcancer
AT dohyunhan reconstructionofpathwaymodificationinducedbynicotinamideusingmultiomicnetworkanalysesintriplenegativebreastcancer
AT hansukryu reconstructionofpathwaymodificationinducedbynicotinamideusingmultiomicnetworkanalysesintriplenegativebreastcancer
_version_ 1718394881643118592